Spin-off for the development and marketing of medical devices and reagents derived from blood components obtained from umbilical cord blood

Episkey is an innovative company that develops medical devices and reagents derived from umbilical cord blood focusing in the field of regenerative medicine; Episkey as the licensee of 2 Policlinico’s patents has developed new medical devices to improve the quality of life of patients suffering from disabling pathologies.

The technology transfer activity represents an opportunity for the creation and development of entrepreneurial realities within a network system in collaboration with local, national and international industrial entities. The TTO also supports to Policlinico researchers for spin-off creation.

To know more,
please contact Policlinico di Milano